ロード中...
Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer
Preoperative characterization of thyroid nodules is challenging since thyroid scintigraphy fails to distinguish between benign and malignant lesions. Galectin-3 (gal-3) is expressed in well-differentiated and in undifferentiated thyroid cancer types but not in normal thyrocytes and benign thyroid le...
保存先:
| 出版年: | J Nucl Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Society of Nuclear Medicine
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6581231/ https://ncbi.nlm.nih.gov/pubmed/30361380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.219105 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|